[LDL cholesterol--why lower and lower?]
- PMID: 18069223
[LDL cholesterol--why lower and lower?]
Abstract
Large interventional studies with statins have confirmed that drug-lowering of LDL cholesterol by at least 25-30% is associated with a significant reduction in the cardiovascular risk. In high-risk patients, the plasma LDL cholesterol level should be < 100 mg/dl. If the levels are initially low, the aim is to achieve a reduction of at least 30-40%. More recent studies have shown that reducing the LDL cholesterol to < 70 mg/dl can stop the further growth of plaques, and can possibly even bring about their regression.
Similar articles
-
Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.Heart. 2008 Jun;94(6):706-14. doi: 10.1136/hrt.2007.125401. Heart. 2008. PMID: 18480348 Review.
-
[Statins--attaining goal values--with reference to recent studies].Wien Med Wochenschr. 1999;149(5-6):144-5. Wien Med Wochenschr. 1999. PMID: 10408006 German.
-
Lipid management with statins. The lower the better?Z Kardiol. 2004 Jan;93(1):4-9. doi: 10.1007/s00392-004-1023-y. Z Kardiol. 2004. PMID: 14740235 Review.
-
[Lower, lower, lower. The LDL goal value of 200 mg/dl is still much too high].MMW Fortschr Med. 2004 Mar 25;146(13):4-5. MMW Fortschr Med. 2004. PMID: 15219114 German. No abstract available.
-
Plasma lipoprotein(a) levels and LDL-cholesterol lowering response to statin therapy in patients with heterozygous familial hypercholesterolemia.Ann Clin Lab Sci. 2006 Summer;36(3):353-5. Ann Clin Lab Sci. 2006. PMID: 16951279
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical